Ibuprofen Zentiva 200 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

ibuprofen zentiva 200 mg

zentiva k.s. - ibuprofen - tablett, filmdrasjert - 200 mg

Ibuprofen Zentiva 400 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

ibuprofen zentiva 400 mg

zentiva k.s. - ibuprofen - tablett, filmdrasjert - 400 mg

Ibuprofen Zentiva 600 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

ibuprofen zentiva 600 mg

zentiva k.s. - ibuprofen - tablett, filmdrasjert - 600 mg

Ibuprofen B. Braun 600 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

ibuprofen b. braun 600 mg

b. braun melsungen ag - ibuprofen - infusjonsvæske, oppløsning - 600 mg

Ibuprofen B. Braun 400 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

ibuprofen b. braun 400 mg

b. braun melsungen ag - ibuprofen - infusjonsvæske, oppløsning - 400 mg

Ibuprofen B. Braun 200 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

ibuprofen b. braun 200 mg

b. braun melsungen ag - ibuprofen - infusjonsvæske, oppløsning - 200 mg

Vildagliptin / Metformin hydrochloride Accord ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, type 2 - legemidler som brukes i diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgjengelige data på forskjellige kombinasjoner).

Ibuprofen Weifa 20 mg/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

ibuprofen weifa 20 mg/ ml

weifa as - ibuprofen - mikstur, suspensjon - 20 mg/ ml

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgjengelige data på forskjellige kombinasjoner).

Pedea ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

pedea

recordati rare diseases - ibuprofen - ductus arteriosus, patent - hjertetapi - behandling av en hemodynamisk signifikant patentsduktus arteriosus hos premature nyfødte spedbarn mindre enn 34 uker med graviditetsalder.